Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.53 |
| ▸ | CA1 | P00915 | 3/20 | 0.46 |
| ▸ | CA2 | P00918 | 3/20 | 0.46 |
| ▸ | CA7 | P43166 | 2/20 | 0.46 |
| ▸ | CA9 | Q16790 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | CA4 | P22748 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3902385 | 1.00 | TDP1 (0.53) | TDP1CA1CA2CA7CA9 | |
| SCHEMBL3899157 | 1.00 | TDP1 (0.53) | TDP1CA1CA2CA7CA9 | |
| SCHEMBL429494 | 1.00 | TDP1 (0.53) | TDP1CA1CA2CA7CA9 | |
| SCHEMBL133184 | 0.98 | TDP1 (0.55) | TDP1CA1CA2CA7CA9 | |
| SCHEMBL29757301 | 0.90 | TDP1 (0.56) | TDP1CA1CA2CA7CA9 | |
| SCHEMBL437165 | 0.87 | TDP1 (0.44) | TDP1CA1CA2CA7CA9 | |
| SCHEMBL439895 | 0.86 | CA1 (0.42) | TDP1CA1CA2CA7CA9 | |
| SCHEMBL3690008 | 0.86 | CA1 (0.42) | TDP1CA1CA2CA7CA9 | |
| SCHEMBL7524404 | 0.86 | CA1 (0.42) | TDP1CA1CA2CA7CA9 | |
| SCHEMBL31626283 | 0.86 | CA1 (0.42) | TDP1CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260035494-A1 | METHOD FOR COLD FLOW REDUCTION OF ELASTOMERS | GOODYEAR TIRE & RUBBER (US) | 2026-02-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260035494-A1 | METHOD FOR COLD FLOW REDUCTION OF ELASTOMERS | ITGA1, HSPA1A, SHC1 | TDP1 1392/4885CA1 1315/4885CA2 2428/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.